These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 11303071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF, Davids JH, Elzinga CR, Wolf D, Zaagsma J, Kilbinger H.
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.
    Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T.
    J Med Chem; 2000 Dec 28; 43(26):5017-29. PubMed ID: 11150173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec 28; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 7. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F, Yageta Y, Segawa M, Matsuzawa S.
    Arzneimittelforschung; 2007 Dec 28; 57(2):92-100. PubMed ID: 17396619
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
    Zhou H, Meyer A, Starke K, Gomeza J, Wess J, Trendelenburg AU.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb 28; 365(2):112-22. PubMed ID: 11819029
    [Abstract] [Full Text] [Related]

  • 10. Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
    Oyasu H, Yamamoto T, Sato N, Sawada T, Ozaki R, Mukai T, Ozaki T, Nishii M, Sato H, Fujiwara T.
    Arzneimittelforschung; 1994 Nov 28; 44(11):1242-9. PubMed ID: 7848339
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
    Ney P, Pandita RK, Newgreen DT, Breidenbach A, Stöhr T, Andersson KE.
    BJU Int; 2008 Apr 28; 101(8):1036-42. PubMed ID: 18279452
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
    Ikeda K, Kobayashi S, Suzuki M, Miyata K, Takeuchi M, Yamada T, Honda K.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug 28; 366(2):97-103. PubMed ID: 12122494
    [Abstract] [Full Text] [Related]

  • 15. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P.
    J Pharmacol Exp Ther; 1997 May 28; 281(2):868-75. PubMed ID: 9152396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle.
    Choppin A, Eglen RM, Hegde SS.
    Br J Pharmacol; 1998 Jul 28; 124(5):883-8. PubMed ID: 9692772
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
    Del Giudice MR, Mustazza C, Borioni A, Gatta F, Tayebati K, Amenta F, Tucci P, Pieretti S.
    Arch Pharm (Weinheim); 2003 Jun 28; 336(3):143-54. PubMed ID: 12822179
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML, Minarini A, Budriesi R, Cacciaguerra S, Chiarini A, Spampinato S, Tumiatti V, Melchiorre C.
    J Med Chem; 1998 Oct 08; 41(21):4150-60. PubMed ID: 9767650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.